Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Huntley (Birmingham, United Kingdom), K. Patel (Birmingham, United Kingdom), A. Mughal (Birmingham, United Kingdom), V. Balbirsingh (Birmingham, United Kingdom), S. Khan (Birmingham, United Kingdom), A. Turner (Birmingham, United Kingdom), D. Lasserson (Birmingham, United Kingdom), M. Newnham (Birmingham, United Kingdom). A multicentre observational study of the prevalence, management and outcomes of subsegmental pulmonary embolism. 3568

Member's Comments

No comment yet.

Related content which might interest you: Multicentre observational screening survey for the detection of CTEPH following pulmonary embolism Source: Eur Respir J, 51 (4) 1702505; 10.1183/13993003.02505-2017 Year: 2018 Diagnosis of pulmonary embolism by chest ultrasound. A prospective multicenter study Source: Eur Respir J 2004; 24: Suppl. 48, 69s Year: 2004 Prevalence of chronic thrombo-embolic pulmonary hypertension after pulmonary embolism: A prospective multicenter study Source: Annual Congress 2010 - Pulmonary hypertension updates Year: 2010 Pulmonary embolism in the multicentre advanced study for a thromboembolism registry (MASTER): study design and patients recruited Source: Eur Respir J 2005; 26: Suppl. 49, 595s Year: 2005 Prevalence of pulmonary embolism in patients with isolated syncope in the emergency department: the PEEPS multicenter prospective cohort study. Source: International Congress 2019 – Pulmonary embolism: from diagnosis to prognosis and treatment Year: 2019 Prognostic factors of pulmonary embolism: results of a prospective multicenter study Source: Annual Congress 2008 - Acute and chronic pulmonary thromboembolic disease Year: 2008 Impact of patients’ setting on the prevalence of pulmonary embolism in acute exacerbation of COPD : a meta-analysis of observational studies. Source: International Congress 2017 – Pulmonary embolism Year: 2017 A retrospective cohort study of patients with pulmonary embolism: the impact of comorbidities on patient's outcome Source: Eur Respir J 2016; 48: 555-557 Year: 2016 Preliminary results of a multicenter study for home treatment of pulmonary embolism (PE) Source: Eur Respir J 2006; 28: Suppl. 50, 365s Year: 2006 Use of bosentan for the treatment of pulmonary arterial hypertension in Spain: a multicenter, retrospective, observational study Source: Annual Congress 2009 - Pulmonary hypertension Year: 2009 Benefits of pulmonary rehabilitation in COVID-19 – a prospective observational cohort study Source: Virtual Congress 2021 – Insights into rehabilitation and physiotherapy in COVID-19 Year: 2021 PEGASUS - the effects of commercial air travel on patients suffering from pulmonary hypertension - a prospective, multicenter, multinational study Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018 PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients Source: International Congress 2016 – IPF clinical Year: 2016 Noninvasive diagnostic strategy in pulmonary embolism: a prospective study in 1,136 out and inpatients Source: Eur Respir J 2001; 18: Suppl. 33, 381s Year: 2001 Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study Source: ERJ Open Res, 6 (1) 00172-2019; 10.1183/23120541.00172-2019 Year: 2020 A retrospective analysis of the outcomes of patients presenting with central pulmonary embolism Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders Year: 2010 Risk of recurrent venous thromboembolism in COPD patients: results from a prospective cohort study Source: Eur Respir J, 50 (1) 1700094; 10.1183/13993003.00094-2017 Year: 2017 A multicentre, observational cohort study to determine the efficacy and safety of lumacaftor/ivacaftor in patients with severe lung disease and cystic fibrosis Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis Year: 2019 Economic evaluation of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: A retrospective, case-controlled, cost of illness study Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation Year: 2010 Safety of riociguat for chronic thromboembolic pulmonary hypertension (CTEPH): Interim data from a prospective non-interventional study in Japan Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018